Company
Tourmaline Bio, Inc. (0001827506)
Standardized SEC financial data for Tourmaline Bio, Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001827506 · Biological Products, (No Diagnostic Substances).
Income statement
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| R&D expense | $15.3M | $34.2M | $17.5M | $32.4M | $67.0M |
| SG&A expense | $7.4M | $13.3M | $2.2M | $13.0M | $22.7M |
| Operating income | -$22.7M | -$47.5M | -$19.7M | -$45.4M |
Standardized from Tourmaline Bio, Inc.'s SEC filings — per-share figures split-adjusted. Full history via the API.
Balance sheet
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2023 | FY2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $17.6M | $18.6M | $8.5M | — | $141.0M | $251.1M |
| Total current assets |
Get 0001827506 data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/0001827506/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/0001827506/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"